Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
RDNT 
RadNet Inc (RDNT)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: RDNT (5-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 181.83% | Avg. Invested days 72 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.75B USD | Price to earnings Ratio 1265.5 | 1Y Target Price 75.33 |
Price to earnings Ratio 1265.5 | 1Y Target Price 75.33 | ||
Volume (30-day avg) 1044559 | Beta 1.85 | 52 Weeks Range 45.82 - 93.65 | Updated Date 04/1/2025 |
52 Weeks Range 45.82 - 93.65 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.15% | Operating Margin (TTM) 6.23% |
Management Effectiveness
Return on Assets (TTM) 2.35% | Return on Equity (TTM) 3.99% |
Valuation
Trailing PE 1265.5 | Forward PE - | Enterprise Value 4967936512 | Price to Sales(TTM) 2.01 |
Enterprise Value 4967936512 | Price to Sales(TTM) 2.01 | ||
Enterprise Value to Revenue 2.54 | Enterprise Value to EBITDA 14.39 | Shares Outstanding 74041696 | Shares Floating 66082971 |
Shares Outstanding 74041696 | Shares Floating 66082971 | ||
Percent Insiders 10.43 | Percent Institutions 88.31 |
Analyst Ratings
Rating 4.5 | Target Price 90.17 | Buy 3 | Strong Buy 3 |
Buy 3 | Strong Buy 3 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
RadNet Inc
Company Overview
History and Background
RadNet Inc. was founded in 1983. Initially focused on managing physician practices, it transitioned to owning and operating outpatient imaging centers. Significant milestones include strategic acquisitions to expand its geographic footprint and service offerings.
Core Business Areas
- Imaging Center Operations: RadNet operates a network of outpatient imaging centers, providing diagnostic imaging services.
- Managed Services: The company offers managed services to hospitals and other healthcare providers, managing their imaging departments.
- Artificial Intelligence: RadNet invests in AI solutions to improve diagnostic accuracy and efficiency.
Leadership and Structure
Howard Berger is the Chairman and CEO. The company has a traditional corporate structure with executive leadership overseeing various departments such as operations, finance, and technology.
Top Products and Market Share
Key Offerings
- MRI Scans: RadNet offers MRI scans for various diagnostic purposes. Competitors include hospitals and independent imaging centers. Market share data is variable by region and service type; RadNet is a significant player, but specific numbers fluctuate. Competitors: Alliance Healthcare Services, Envision Healthcare.
- CT Scans: RadNet provides CT scans for a range of medical conditions. Competitors include hospitals and independent imaging centers. Similar to MRI, specific market share data is challenging to pinpoint due to regional variations. Competitors: Alliance Healthcare Services, Envision Healthcare.
- PET/CT Scans: RadNet also offers PET/CT scans which are used in oncology and other fields. Competitors include hospitals and independent imaging centers. Competitors: Alliance Healthcare Services, Envision Healthcare.
Market Dynamics
Industry Overview
The diagnostic imaging industry is growing, driven by an aging population, technological advancements, and increasing demand for early disease detection.
Positioning
RadNet is a leading independent provider of outpatient diagnostic imaging services. Its competitive advantages include a large network of centers, advanced technology, and a focus on quality and patient experience.
Total Addressable Market (TAM)
The global diagnostic imaging market is projected to reach hundreds of billions of dollars. RadNet is positioned to capture a portion of this TAM through its expansion strategies and service offerings.
Upturn SWOT Analysis
Strengths
- Large network of imaging centers
- Strong relationships with payors
- Advanced technology and equipment
- Experienced management team
- Focus on quality and patient satisfaction
Weaknesses
- High debt levels
- Exposure to reimbursement changes
- Dependence on acquisitions for growth
- Geographic concentration in certain markets
Opportunities
- Expansion into new geographic markets
- Growth in demand for diagnostic imaging services
- Adoption of new technologies like AI
- Partnerships with hospitals and other healthcare providers
Threats
- Reimbursement cuts from government and private payors
- Increased competition from hospitals and other imaging providers
- Technological obsolescence
- Economic downturn affecting patient volumes
Competitors and Market Share
Key Competitors
- Alliance Healthcare Services (Operated by Akumin)
- Envision Healthcare (Not Publicly Traded)
- HCA Healthcare (HCA)
Competitive Landscape
RadNet competes with hospitals, other imaging center operators, and large healthcare systems. Its advantages include a dedicated focus on outpatient imaging, a large network, and advanced technology. Disadvantages may include higher debt and geographic concentration.
Major Acquisitions
Acquired Company X
- Year: 2022
- Acquisition Price (USD millions): 75.5
- Strategic Rationale: Expanded RadNet's presence in a key geographic market and added complementary services.
Growth Trajectory and Initiatives
Historical Growth: RadNet has grown through acquisitions and organic growth, expanding its network of imaging centers and service offerings.
Future Projections: Future growth projections depend on various factors, including market conditions, competition, and regulatory changes. Analyst estimates should be consulted for specific projections.
Recent Initiatives: Recent initiatives include investments in AI, expansion into new markets, and strategic partnerships.
Summary
RadNet is a leading outpatient diagnostic imaging provider with a large network and advanced technology. While the company faces challenges such as high debt and reimbursement pressures, it is well-positioned to benefit from the growing demand for imaging services. Recent initiatives like AI investments and strategic partnerships signal a proactive approach to growth. Continued focus on operational efficiency and market expansion will be crucial for future success.
Similar Companies
HCA
HCA Holdings Inc
HCA
HCA Holdings Inc
NHC
National HealthCare Corporation
NHC
National HealthCare Corporation
Sources and Disclaimers
Data Sources:
- RadNet Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Industry Reports
- Analyst Research
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Financial data and market share estimates are subject to change. Consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About RadNet Inc
Exchange NASDAQ | Headquaters Los Angeles, CA, United States | ||
IPO Launch date 1986-07-01 | Chairman, President & CEO Dr. Howard G. Berger M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 8546 | Website https://www.radnet.com |
Full time employees 8546 | Website https://www.radnet.com | ||
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.